Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of key clinical and preclinical milestones SEATTLE, WA / ACCESS Newswire / Janu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback